Board of Directors

The Cytokinetics Board of Directors contributes know-how, wisdom, supervision and oversight to our business and drug discovery and development activities. The Board members bring decades of pertinent expertise and proficiency as industry executives, investors and academics to bear on key business and research and Development strategies and company implementation.

Members

Robert I. Blum
Cytokinetics, Inc.

Steve Dow
Sevin Rosen Funds

L. Patrick Gage, Ph.D. (Chairman)
Industry Consultant

Denise M. Gilbert, Ph.D.
Industry Consultant

A. Grant Heidrich, III
Partner Emeritus, Mayfield Fund

John Henderson
Industry Consultant

Michael Schmertzler
CEO, Kolltan Pharmaceuticals
Managing Partner, Aries Advisors, LLC

James Spudich, Ph.D.
Stanford School of Medicine